UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.1B |
| 2 |
NVIDIA
NVDA
|
+$2.82B |
| 3 |
Microsoft
MSFT
|
+$2.29B |
| 4 |
Amazon
AMZN
|
+$1.67B |
| 5 |
UnitedHealth
UNH
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.42B |
| 2 |
Amphenol
APH
|
+$419M |
| 3 |
Iron Mountain
IRM
|
+$322M |
| 4 |
HDFC Bank
HDB
|
+$212M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 12.99% |
| 3 | Consumer Discretionary | 11.48% |
| 4 | Healthcare | 10.94% |
| 5 | Communication Services | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GATO
2351
DELISTED
Gatos Silver, Inc.
GATO
| $958K | ﹤0.01% |
68,539
+13,092
| +24% | +$213K |
|
|
DAWN
2352
DELISTED
Day One Biopharmaceuticals
DAWN
| $958K | ﹤0.01% |
75,579
+10,386
| +16% | +$145K |
|
2353
Phathom Pharmaceuticals
PHAT
$731M
| $957K | ﹤0.01% |
117,803
+19,778
| +20% | +$245K |
|
|
PLYM
2354
DELISTED
Plymouth Industrial REIT
PLYM
| $954K | ﹤0.01% |
53,573
-13,628
| -20% | -$269K |
|
2355
EverQuote
EVER
$886M
| $950K | ﹤0.01% |
47,500
+12,118
| +34% | +$229K |
|
2356
First Community Bankshares
FCBC
$899M
| $947K | ﹤0.01% |
22,737
+815
| +4% | +$35.9K |
|
2357
Vermilion Energy
VET
$1.76B
| $946K | ﹤0.01% |
100,635
-34,486
| -26% | -$336K |
|
|
CVAC
2358
DELISTED
CureVac
CVAC
| $943K | ﹤0.01% |
276,505
-661
| -0.2% | -$1.91K |
|
2359
Astronics
ATRO
$3.38B
| $937K | ﹤0.01% |
70,424
+30,175
| +75% | +$443K |
|
2360
Fulgent Genetics
FLGT
$574M
| $936K | ﹤0.01% |
50,654
+5,986
| +13% | +$117K |
|
|
DHIL
2361
DELISTED
Diamond Hill
DHIL
| $936K | ﹤0.01% |
6,032
-336
| -5% | -$53.8K |
|
|
CHCT
2362
Community Healthcare Trust
CHCT
$530M
| $934K | ﹤0.01% |
48,643
+3,978
| +9% | +$72.1K |
|
2363
FuboTV Inc
FUBO
$253M
| $933K | ﹤0.01% |
61,732
+27,268
| +79% | +$500K |
|
2364
Miller Industries
MLR
$569M
| $933K | ﹤0.01% |
14,276
-1,216
| -8% | -$82.8K |
|
2365
Community Trust Bancorp
CTBI
$1.42B
| $926K | ﹤0.01% |
17,454
+5,929
| +51% | +$325K |
|
|
GES
2366
DELISTED
Guess Inc
GES
| $925K | ﹤0.01% |
65,819
+11,131
| +20% | +$190K |
|
2367
Nuvation Bio
NUVB
$2.33B
| $925K | ﹤0.01% |
347,806
+122,187
| +54% | +$315K |
|
2368
Equity Bancshares
EQBK
$1.04B
| $924K | ﹤0.01% |
21,773
+4,554
| +26% | +$202K |
|
2369
Arcus Biosciences
RCUS
$3.55B
| $923K | ﹤0.01% |
62,014
-7,872
| -11% | -$129K |
|
2370
Ituran Location and Control
ITRN
$1.1B
| $923K | ﹤0.01% |
29,629
+2,075
| +8% | +$59K |
|
2371
Community Health Systems
CYH
$391M
| $921K | ﹤0.01% |
308,176
+18,612
| +6% | +$78.2K |
|
2372
Enanta Pharmaceuticals
ENTA
$378M
| $918K | ﹤0.01% |
159,729
-10,886
| -6% | -$104K |
|
2373
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $915K | ﹤0.01% |
3,180
+1,730
| +119% | +$512K |
|
|
HOUS
2374
DELISTED
Anywhere Real Estate
HOUS
| $913K | ﹤0.01% |
276,583
+31,313
| +13% | +$134K |
|
2375
Peapack-Gladstone Financial
PGC
$815M
| $912K | ﹤0.01% |
28,467
+2,272
| +9% | +$75.3K |
|
Similar funds
UBS AM's Q4 2024 Portfolio in Review
As of Q4 2024, UBS AM held 2,799 positions worth $429B, up 10% from $389B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
UBS AM deployed $33.4B of net new capital in Q4 2024, opening 50 new positions and adding to 1,945 existing holdings. Its largest new stake was Xtrackers MSCI USA Climate Action Equity ETF: 1,587,581 shares worth $58.8M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Pinduoduo, an estimated $1.42B trimmed.
- UBS AM's largest Q4 2024 buy was Xtrackers MSCI USA Climate Action Equity ETF: 1,587,581 shares worth $58.8M.
- UBS AM added most to Apple in Q4 2024, an estimated $3.1B increase.
- UBS AM's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $1.42B.
- UBS AM fully exited iShares MSCI India ETF in Q4 2024, selling an estimated $176M.
- UBS AM's ten largest holdings make up 32% of its $429B portfolio in Q4 2024.
- UBS AM opened 50 new positions and closed 145 in Q4 2024.
- UBS AM's portfolio value rose 10% quarter-over-quarter to $429B.
Based on UBS AM's 13F filing for Q4 2024, filed 14 Feb 2025.